AAAAAA

   
Results: 1-9 |
Results: 9
USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITHFLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: ESTEY E THALL P ANDREEFF M BERAN M KANTARJIAN H OBRIEN S ESCUDIER S ROBERTSON LE KOLLER C KORNBLAU S PIERCE S FREIREICH E DEISSEROTH A KEATING M
Citation: E. Estey et al., USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITHFLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 12(4), 1994, pp. 671-678
IDENTIFICATION OF HYPERGLYCOSYLATED E-SELECTING (ELAM-1) EXPRESSION ON NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS
Authors: KOBERDA J PRZEPIORKA D BEDNARCZYK J ESCUDIER S CHAMPLIN RE DEISSEROTH AB MCINTYRE BW
Citation: J. Koberda et al., IDENTIFICATION OF HYPERGLYCOSYLATED E-SELECTING (ELAM-1) EXPRESSION ON NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS, Experimental hematology, 22(8), 1994, pp. 711-711
HIGH-INCIDENCE OF MONOSOMY-18 IN LYMPHOID MALIGNANCIES THAT HAVE BONE-MARROW AND PERIPHERAL-BLOOD INVOLVEMENT
Authors: YOUNES A JENDIROBA D ENGEL H ESCUDIER S KATZ R RODRIGUEZ MA HILL D CABANILLAS F ANDREEFF M
Citation: A. Younes et al., HIGH-INCIDENCE OF MONOSOMY-18 IN LYMPHOID MALIGNANCIES THAT HAVE BONE-MARROW AND PERIPHERAL-BLOOD INVOLVEMENT, Cancer genetics and cytogenetics, 77(1), 1994, pp. 39-44
TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH AML-TYPE CHEMOTHERAPY
Authors: ESTEY E PIERCE S KANTARJIAN H OBRIEN S BERAN M ANDREEFF M ESCUDIER S KOLLER C KORNBLAU S ROBERTSON L KEATING M
Citation: E. Estey et al., TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH AML-TYPE CHEMOTHERAPY, Leukemia & lymphoma, 11, 1993, pp. 59-63
PRELIMINARY-RESULTS OF TREATMENT WITH FILGRASTIM FOR RELAPSE OF LEUKEMIA AND MYELODYSPLASIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: GIRALT S ESCUDIER S KANTARJIAN H DEISSEROTH A FREIREICH EJ ANDERSSON BS OBRIEN S ANDREEFF M FISHER H CORK A HIRSCHGINSBERG C TRUJILLO J STASS S CHAMPLIN RE
Citation: S. Giralt et al., PRELIMINARY-RESULTS OF TREATMENT WITH FILGRASTIM FOR RELAPSE OF LEUKEMIA AND MYELODYSPLASIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 329(11), 1993, pp. 757-761
IDENTIFICATION OF E-SELECTIN (ELAM-1) ON NORMAL HUMAN HEMATOPOIETIC-CELLS
Authors: KOBERDA J PRZEPIORKA D BEDNARCZYK J ESCUDIER S DEISSEROTH A MCINTYRE B
Citation: J. Koberda et al., IDENTIFICATION OF E-SELECTIN (ELAM-1) ON NORMAL HUMAN HEMATOPOIETIC-CELLS, Blood, 82(10), 1993, pp. 10000031-10000031
MONOSOMY-18 IS MORE COMMON IN LYMPHOID MALIGNANCIES WITH HIGH-INCIDENCE OF BONE-MARROW AND PERIPHERAL-BLOOD INVOLVEMENT
Authors: YOUNES A JENDIROBA D ENGEL H ESCUDIER S KHOURY P KATZ R HILL D RODRIGUEZ MA CABANILLAS F ANDREEFF M
Citation: A. Younes et al., MONOSOMY-18 IS MORE COMMON IN LYMPHOID MALIGNANCIES WITH HIGH-INCIDENCE OF BONE-MARROW AND PERIPHERAL-BLOOD INVOLVEMENT, Blood, 82(10), 1993, pp. 10000044-10000044
MODIFIED BURKITT REGIMEN FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) -THE HYPER-CVAD PROGRAM
Authors: KANTARJIAN H OBRIEN S BERAN M ESCUDIER S PIERCE S ESTEY E KOLLER C ROBERTSON B ANDREEFF M KEATING M BOWMAN P MURPHY S FREIREICH E
Citation: H. Kantarjian et al., MODIFIED BURKITT REGIMEN FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) -THE HYPER-CVAD PROGRAM, Blood, 82(10), 1993, pp. 10000329-10000329
MULTIDRUG-RESISTANCE (MDR1) AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: ESCUDIER S ZHAO S LIU Y KLEINE HD OBRIEN S ANDREEFF M
Citation: S. Escudier et al., MULTIDRUG-RESISTANCE (MDR1) AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 82(10), 1993, pp. 10000563-10000563
Risultati: 1-9 |